Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Sep;76(9):1249–1254. doi: 10.1136/jnnp.2004.051003

Increased platelet count and leucocyte–platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis

D McCabe 1, P Harrison 1, I Mackie 1, P Sidhu 1, G Purdy 1, A Lawrie 1, H Watt 1, S Machin 1, M Brown 1
PMCID: PMC1739812  PMID: 16107361

Abstract

Objective: The risk of stroke in patients with recently symptomatic carotid stenosis is considerably higher than in patients with asymptomatic stenosis. In the present study it was hypothesised that excessive platelet activation might partly contribute to this difference.

Methods: A full blood count was done and whole blood flow cytometry used to measure platelet surface expression of CD62P, CD63, and PAC1 binding and the percentage of leucocyte–platelet complexes in patients with acute (0–21 days, n = 19) and convalescent (79–365 days) symptomatic (n = 16) and asymptomatic (n = 16) severe (⩾70%) carotid stenosis. Most patients were treated with aspirin (37.5–300 mg daily) although alternative antithrombotic regimens were more commonly used in the symptomatic group.

Results: The mean platelet count was higher in patients with acute and convalescent symptomatic compared with asymptomatic carotid stenosis. There were no significant differences in the median percentage expression of CD62P and CD63, or PAC1 binding between the acute or convalescent symptomatic and asymptomatic patients. The median percentages of neutrophil–platelet (p = 0.004), monocyte–platelet (p = 0.046), and lymphocyte–platelet complexes (p = 0.02) were higher in acute symptomatic than in asymptomatic patients. In patients on aspirin monotherapy, the percentages of neutrophil–platelet and monocyte–platelet complexes (p = 0.03) were higher in acute symptomatic (n = 11) than asymptomatic patients (n = 14). In the convalescent phase, the median percentages of all leucocyte–platelet complexes in the symptomatic group dropped to levels similar to those found in the asymptomatic group.

Conclusion: Increased platelet count and leucocyte–platelet complex formation may contribute to the early excess risk of stroke in patients with recently symptomatic carotid stenosis.

Full Text

The Full Text of this article is available as a PDF (86.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams C., Shattil S. J. Immunological detection of activated platelets in clinical disorders. Thromb Haemost. 1991 May 6;65(5):467–473. [PubMed] [Google Scholar]
  2. Akopov S. E., Simonian N. A., Grigorian G. S. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke. 1996 Oct;27(10):1739–1743. doi: 10.1161/01.str.27.10.1739. [DOI] [PubMed] [Google Scholar]
  3. Butterworth R. J., Bath P. M. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets. 1998;9(6):359–364. doi: 10.1080/09537109876429. [DOI] [PubMed] [Google Scholar]
  4. Celi A., Pellegrini G., Lorenzet R., De Blasi A., Ready N., Furie B. C., Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8767–8771. doi: 10.1073/pnas.91.19.8767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cha Jae-Kwan, Jeong Min-Ho, Jang Ji-Yeon, Bae Hae-Rahn, Lim Yeong-Jin, Kim Jung Sun, Kim Sang-Ho, Kim Jae Woo. Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis. 2003;16(4):376–382. doi: 10.1159/000072560. [DOI] [PubMed] [Google Scholar]
  6. Furman M. I., Barnard M. R., Krueger L. A., Fox M. L., Shilale E. A., Lessard D. M., Marchese P., Frelinger A. L., 3rd, Goldberg R. J., Michelson A. D. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol. 2001 Oct;38(4):1002–1006. doi: 10.1016/s0735-1097(01)01485-1. [DOI] [PubMed] [Google Scholar]
  7. Golledge J., Greenhalgh R. M., Davies A. H. The symptomatic carotid plaque. Stroke. 2000 Mar;31(3):774–781. doi: 10.1161/01.str.31.3.774. [DOI] [PubMed] [Google Scholar]
  8. Grau A. J., Ruf A., Vogt A., Lichy C., Buggle F., Patscheke H., Hacke W. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost. 1998 Aug;80(2):298–301. [PubMed] [Google Scholar]
  9. Israels S. J., Gerrard J. M., Jacques Y. V., McNicol A., Cham B., Nishibori M., Bainton D. F. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood. 1992 Jul 1;80(1):143–152. [PubMed] [Google Scholar]
  10. Joseph J. E., Harrison P., Mackie I. J., Isenberg D. A., Machin S. J. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol. 2001 Nov;115(2):451–459. doi: 10.1046/j.1365-2141.2001.03101.x. [DOI] [PubMed] [Google Scholar]
  11. Li N., Hu H., Lindqvist M., Wikström-Jonsson E., Goodall A. H., Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2702–2708. doi: 10.1161/01.atv.20.12.2702. [DOI] [PubMed] [Google Scholar]
  12. McCabe Dominick J. H., Harrison Paul, Mackie Ian J., Sidhu Paul S., Purdy Gordon, Lawrie Andrew S., Watt Hilary, Brown Martin M., Machin Samuel J. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol. 2004 Jun;125(6):777–787. doi: 10.1111/j.1365-2141.2004.04983.x. [DOI] [PubMed] [Google Scholar]
  13. Mendelsohn M. E., Loscalzo J. Role of platelets in cholesteryl ester formation by U-937 cells. J Clin Invest. 1988 Jan;81(1):62–68. doi: 10.1172/JCI113311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Michelson A. D., Barnard M. R., Krueger L. A., Valeri C. R., Furman M. I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001 Sep 25;104(13):1533–1537. doi: 10.1161/hc3801.095588. [DOI] [PubMed] [Google Scholar]
  15. Michelson A. D. Flow cytometry: a clinical test of platelet function. Blood. 1996 Jun 15;87(12):4925–4936. [PubMed] [Google Scholar]
  16. Moneta G. L., Edwards J. M., Chitwood R. W., Taylor L. M., Jr, Lee R. W., Cummings C. A., Porter J. M. Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vasc Surg. 1993 Jan;17(1):152–159. doi: 10.1067/mva.1993.42888. [DOI] [PubMed] [Google Scholar]
  17. Numminen H., Hillbom M., Juvela S. Platelets, alcohol consumption, and onset of brain infarction. J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):376–380. doi: 10.1136/jnnp.61.4.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. O'Malley T., Langhorne P., Elton R. A., Stewart C. Platelet size in stroke patients. Stroke. 1995 Jun;26(6):995–999. doi: 10.1161/01.str.26.6.995. [DOI] [PubMed] [Google Scholar]
  19. Shattil S. J., Cunningham M., Hoxie J. A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987 Jul;70(1):307–315. [PubMed] [Google Scholar]
  20. de Bruijne-Admiraal L. G., Modderman P. W., Von dem Borne A. E., Sonnenberg A. P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood. 1992 Jul 1;80(1):134–142. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES